Fractyl Health GUTS
NASDAQ GUTS
$0.78 +0.09 (+13.85%)
At close: Aug 21, 2026 · 4:00 PM EDT

Fractyl Health (GUTS) Change in Account Payables (2023 - 2026)

Fractyl Health's (GUTS) quarterly Change in Account Payables came in at $75000.0 in Q1 2026, up 104.26% YoY from $36718.1 in Q1 2025, and down 76.42% on a QoQ basis from $318000.0 in Q4 2025.

Fractyl Health (GUTS) Change in Account Payables (2023 - 2026) Analysis & Trends

Fractyl Health (GUTS) has 4 years of Change in Account Payables data on file, last reported at $75000.0 in Q1 2026.

  • Quarterly Change in Account Payables rose 104.26% year-over-year to $75000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $170000.0 (down 60.56% YoY) and the FY2025 annual result came in at -$1.7 million, down 162.03% from the prior year.
  • Change in Account Payables retreated to $75000.0 in Q1 2026, from $318000.0 in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $2.4 million in Q2 2025 to a low of -$2.7 million in Q3 2025.
  • A 4-year average of $51384.6 and a median of $75000.0 in 2026 frame the typical range for Change in Account Payables.
  • Annual changes were most pronounced in 2024 — Change in Account Payables surged 1854.55% — and 2025, when it slumped 652.12%.
  • Tracing GUTS's Change in Account Payables over 4 years: stood at $77000.0 in 2023, then surged by 1854.55% to $1.5 million in 2024, then slumped by 78.87% to $318000.0 in 2025, then plunged by 76.42% to $75000.0 in 2026.
  • The last three Change in Account Payables figures came in at $75000.0 (Q1 2026), $318000.0 (Q4 2025), and -$2.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -66.70 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -8.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 37.53 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Fractyl Health 123.81 Mn 123.81 Mn - -643,000.00

Historic Data

Download Data
DateValue
Jun 30, 2026 -643,000.00
Jun 30, 2026 -643,000.00
Mar 31, 2026 75,000.00
Mar 31, 2026 75,000.00
Dec 31, 2025 318,000.00
Dec 31, 2025 318,000.00
Sep 30, 2025 -2.66 Mn
Sep 30, 2025 -2.66 Mn
Jun 30, 2025 2.43 Mn
Jun 30, 2025 2.43 Mn
Mar 31, 2025 -1.76 Mn
Mar 31, 2025 -1.76 Mn
Dec 31, 2024 1.51 Mn
Dec 31, 2024 1.51 Mn
Sep 30, 2024 -353,000.00
Sep 30, 2024 -353,000.00
Jun 30, 2024 1.04 Mn
Jun 30, 2024 1.04 Mn
Mar 31, 2024 494,000.00
Mar 31, 2024 494,000.00